Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function.
D000136:Acid-Base Equilibrium; D000141:Acidosis, Renal Tubular / Q000139:chemically induced; D000666:Amphotericin B / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001759:Blastomycosis / Q000188:drug therapy; D002245:Carbon Dioxide / Q000378:metabolism; D005919:Glomerular Filtration Rate; D006660:Histoplasmosis / Q000188:drug therapy; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007008:Hypokalemia / Q000139:chemically induced; D007674:Kidney Diseases / Q000139:chemically induced*; D007684:Kidney Tubules / Q000187:drug effects*; D009181:Mycoses / Q000188:drug therapy; D010313:Partial Pressure; D011188:Potassium / Q000652:urine; D014527:Uric Acid / Q000652:urine
D002245:Carbon Dioxide; D014527:Uric Acid; D000666:Amphotericin B; D011188:Potassium